CLSD 1 (-0.99%)
US1850631045BiotechnologyBiotechnology

Clearside Biomedical (CLSD) Stock Highlights

1 | -0.99%
2024-08-29 05:19:49
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

Statistics

Range Today
0.97 1.03
Volume Today 271.2K
Range 1 Year
0.65 2.12
Volume 1 Year 55.46M
Range 3 Year
0.65 7.73
Volume 3 Year 231.45M
Range 10 Year
0.56 25.08
Volume 10 Year 1.03B

Highlights

Market Capitalization 76.24M (small)
Floating Shares 69.14M
Current Price 1
Price To Earnings -2.02
Price To Revenue 12.56
Earnings Per Share -0.5
Payout Ratio 0%

Performance

Latest -0.99%
1 Month -15.25%
3 Months -24.81%
6 Months -26.47%
1 Year +7.53%
3 Years -86.09%
5 Years +69.49%
10 Years -87.5%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.